Next Article in Journal
Scientific Justification and Policy Recommendations to the US Food and Drug Administration for Waiving Comparative Efficacy Studies
Next Article in Special Issue
Indazole Derivatives Against Murine Cutaneous Leishmaniasis
Previous Article in Journal
Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia—An Inpatient Welfare Institution-Based Cross-Sectional Study
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(6), 778; https://doi.org/10.3390/ph18060778
Action Date Notes Link
article html file updated 25 June 2025 05:42 CEST Update https://www.mdpi.com/1424-8247/18/6/778/html
article html file updated 23 May 2025 09:04 CEST Original file -
article supplementary file uploaded. 23 May 2025 09:02 CEST - https://www.mdpi.com/1424-8247/18/6/778#supplementary
article pdf uploaded. 23 May 2025 09:02 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/778/pdf
article xml uploaded. 23 May 2025 09:02 CEST Update https://www.mdpi.com/1424-8247/18/6/778/xml
article xml file uploaded 23 May 2025 09:02 CEST Original file -
Back to TopTop